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     INTRODUCTION 
  Although pyelonephritis affects only 1–2% of pregnant 
women, it is accompanied by significant maternal morbidity 
and fetal morbidity and mortality.  1–  3   Pyelonephritis can result 
in premature labor in 20–30% of women, and these infants are 
at high risk of neonatal death in resource-limited settings.  4,  5  
Lack of access to microbiological facilities in these settings 
prevents antenatal care programs from providing the recom-
mended  6–  10   routine urine culture to detect asymptomatic bac-
teriuria. This results in a failure to promptly diagnose urinary 
tract infection (UTI) and provide appropriate antimicrobial 
therapy. 
  Most resource-limited settings are also unlikely to have the 
information that they need to guide empiric antimicrobial 
therapy.  11,  12   Diagnosis and susceptibility profiles of urinary 
pathogens are hampered by numerous factors in populations 
such as displaced people living on the Thai–Burmese border. 
Difficulties in obtaining a clean urine sample, transportation 
limitations that can prevent timely arrival of specimens from 
the clinic to a microbiological facility, and use of shop-bought 
antibiotics or yaa-chud, which has been reported to contain 
antibiotics,  13   could inhibit culture growth. In addition, there is 
a perceived lack of need on the part of the main health provid-
ers to collate such data for local populations. 
  Resource-limited settings are more likely to have access 
to microscopy than culture facilities. Reports on microscopy 
of the urine sediment in pregnancy refer mostly to its role in 
screening for asymptomatic bacteriuria.  14   Boucher and oth-
ers  14   advocated that microscopy of urine sediment be stopped 
after urine culture was routine for screening at antenatal care 
clinics. One Turkish study found the sensitivity and specificity 
of microscopic urinalysis were 71.0% and 73.6%, respectively, 
in women with asymptomatic bacteriuria and symptomatic 
UTI, which was considerably higher than corresponding fig-
ures for dipstick testing of 38.7% and 35.8%, respectively; 
they elected to continue urine microscopy, because routine 
culture was not available.  15   In a pregnant population in rural 
Australia, the positive predictive value of dipstick urinalysis in 
diagnosing asymptomatic bacteriuria was reported to be low 
(33.5%).  16   Microscopy of urine sediment was introduced by 
Médecins sans Frontières in laboratories in refugee camps on 
the Thai–Burmese border, but the sensitivity and specificity 
for diagnosis of UTI has never been formally tested. 
  Although 10–14 days therapy is accepted for treatment of 
pyelonephritis,  17   particularly in pregnant women, new stud-
ies are challenging the duration of therapy.  18   The  treatment 
choice for pyelonephritis in pregnant women is limited. 
Antimicrobial drug resistance is rising at an alarming rate, 
with very few new treatment options for Gram-negative bac-
teria in non-pregnant and pregnant individuals.  19   The rise of 
extended spectrum β-lactamase (ESBL)-producing bacteria is 
compounding the problem, because antimicrobials such as the 
cephalosporins, which have a good safety profile in pregnant 
women, are rendered ineffective. Only four randomized con-
trol trials in pregnant women including 90,  20   178, 21   179, 22   and 
101,  23   or 548 women in total, have assessed antimicrobial effi-
cacy. These studies concluded that in non-bacteremic patients, 
oral cephalexin (500 mg every 6 hours) did not differ in effi-
cacy and safety from intravenous (IV) cephalothin (1 g every 6 
hours) treatment  20  ; one time daily IV ceftriaxone was as effec-
tive as multiple daily doses of cefazolin.  22  No difference in clin-
ical response was observed with IV ampicillin and gentamicin, 
IV cefazolin, or intramuscular ceftriaxone,  23   whereas cefu-
roxime (750 mg every 8 hours IV      ) was more efficacious and 
better tolerated than cephradine (1 g every 6 hours IV).  21   A 
review article reported that 2 weeks of therapy seems accept-
able for treatment of acute pyelonephritis in women, not spe-
cifically pregnant women  24  ; nevertheless, 10- to 14-day courses 
are suggested.  25,  26  
  Here, we report the incidence, risk factors, diagnosis, micro-
bial pathogens, antimicrobial susceptibilities, and outcome of 
pregnancies associated with pyelonephritis in antenatal clin-
ics attended by refugees and migrants on the Thai–Burmese 
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border. This aims to provide information to guide future 
empiric prescribing in this population, stimulate interest in 
surveillance work by non-government organizations (NGOs) 
responsible for the health of populations, and highlight the 
need for field-adapted susceptibility testing. 
   MATERIALS AND  METHODS 
  The 41 pregnant women included were also included in 
a manuscript on the causes of fever in pregnancy published 
elsewhere.  27  
    Study sites and population.     At the time of this study, the 
Shoklo Malaria Research Unit conducted antenatal clinics 
on a weekly basis in Tak province, Northwest Thailand for 
approximately 800 pregnant Karen and Burmese women in 
Maela Refugee Camp and 300 migrant pregnant women in 
four villages (Maw Ker Thai, Murunchai, Walley, and later, 
Wang Pha). This is an area endemic for  Plasmodium falciparum  
and   P. vivax   malaria 28   with a low seroprevalence of human 
immunodeficiency virus (HIV) infection (< 0.5%).  29  
  Before this study, antenatal screening for asymptomatic bac-
teriuria was done at 28 weeks gestation, which coincides with 
fetal viability in this setting. Pregnant women had mid-stream 
specimens of urine screened for blood and protein by dipstick 
(ROCHE Combur7 test D), and if the result was positive, the 
sample was centrifuged, and the sediment was examined by 
microscopy. No routine microbiology was available before this 
study. 
   Inclusion  and  exclusion  criteria.     We included any pregnant 
woman with confirmed fever (aural temperature > 37.5°C) who 
could give written informed consent and was able to follow 
a supervised treatment regimen. There were no exclusion 
criteria. Febrile women who did not want to participate in 
the study were provided with the same level of care as study 
participants. The consent form and information sheet for 
the study were available in Karen and Burmese languages. 
A trained study midwife read the forms to women who were 
unable to read. 
      Laboratory procedures and sample collection.   After  clinical 
examination, each pregnant woman had a standardized set 
of laboratory investigations to maximize the prospect of 
positively identifying the pathogen(s) causing her fever and to 
study comorbidities. The investigations reported here include 
urine dipstick, urine sediment microscopy, urine culture from a 
clean mid-stream urine sample, a 5-mL blood culture collected 
into a BacT/ALERT FA aerobic blood culture bottle, and 
complete blood count results. Midwives were trained in the 
specific instructions required for the urine sample collection. 
Instructions were given to each woman by the midwife. The 
cup with the clean catch urine was brought directly back to 
the midwives and sent to the field laboratory for processing. 
Samples for stick testing, microscopy, and culture were all 
prepared from the same urine specimen within 5 minutes 
of arrival to the laboratory. The urine stick and microscopy 
could be read on site, but the culture specimen was placed 
into a 10-mL plain sterile tube and maintained in the fridge 
for a few hours before being transported in an icebox to the 
microbiology laboratory in Mae Sot. Blood culture bottles 
were handled at room temperature until they reached the 
microbiology laboratory. There was no routine transport to 
the microbiology laboratory on Sunday, and samples collected 
before transport on Monday were stored at 4°C (urine) or room 
ambient temperature (blood culture; ambient temperature is 
approximately 30°C). 
      Urine stick and sediment microscopy.    The  urine  dipstick 
(ROCHE Combur-10-test UV/M) was completely immersed 
in the urine, placed flat on a bench top for 60 seconds, and then 
read by the study technician. The test was considered positive 
if both nitrites and leukocytes were positive. A volume of 
10 mL of fresh urine was centrifuged at 800 ×   g   for 5 minutes. 
One drop of sediment was placed on a slide, and a coverslip 
was applied. The urine was examined with light microscopy 
using objective × 40 for 10 fields for each of the following: 
white blood cells (WBC), red blood cells (RBC), epithelial 
cells, crystals (cystine, oxalate, and phosphate), casts (granular, 
RBC, WBC, and hyaline), bacteria, yeast, and   Trichomonas . 
The total count was divided by 10 to obtain the average per 
HPF. The minimum and maximum count from the 10 fields was 
also reported. Microscopy of urine sediment was considered 
contaminated when it contained ≥ 5 epithelial cells/high 
powered field (HPF; minimum value of the range). Sediment 
was considered positive when epithelial cells were < 5/HPF 
and there were bacteria (≥ 1+) and WBC (≥ 10/HPF; minimum 
value of the range) identified in the sediment. In centrifuged 
urine, 1+ = 1–10 bacteria/HPF, 2+ = 11–100 bacteria/HPF, 3+ 
≥ 100 bacteria/HPF, and 4+ = field packed with organisms.  30  
   Bacteriological  culture.     Quantitative urine culture was 
performed by using a sterile loop to inoculate 0.001 mL 
urine onto a 5% sheep blood agar and a MacConkey agar 
plate (Oxoid, Basingstoke, Hampshire, United Kingdom). All 
plates were incubated in air at 35°C and read at 24 and 48 
hours for bacterial identification and colony count. Isolates 
from specimens containing a single bacterial colony type at 
greater than or equal to 10  5   colony-forming unit (cfu)/mL 
were identified, and antimicrobial susceptibility tests were 
performed. The relevance of urine containing a single colony 
type between 10  4   and 10  5   cfu/mL was determined based on 
clinical features. Cultures were considered contaminated 
if more than one organism or non-pathogen were isolated. 
Cases with contaminated cultures were removed from further 
analysis. Blood samples were inoculated aseptically into blood 
culture BacT/ALERT FA bottles (BioMérieux, Durham, NC      ) 
containing 30 mL of media, activated charcoal, and an internal 
sensor that detects carbon dioxide as an indicator of microbial 
growth. Blood culture bottles were vented (using BCB Vent/
Sub units; Difco, West Molesey, Surrey, United Kingdom) 
immediately and incubated unshaken in air for 7 days at 37°C. 
Gram stains were performed on smears prepared at 12–24 
hours and 36–48 hours or when the sensor indicated growth. 
Bottles were subcultured routinely onto blood agar at 12–24 
hours and 36–48 hours and after 7 days of incubation, and 
they were subcultured on days 3–6 if there was any suggestion 
of visible growth (that is, indicator changed). Antimicrobial 
susceptibility (including the detection of ESBL activity) was 
determined using disk diffusion methodology in accordance 
with Clinical and Laboratory Standards Institute       guidelines.  31  
   Clinical  procedures  and  definitions.   Women  who  consented 
to the study were given a study code, and a case record form was 
completed by the doctor on duty. All women were admitted to 
hospital, had their medical and obstetric history reviewed, and 
were given a full examination by a physician and a midwife. 
Patients’ symptoms were defined and recorded using a 
standardized checklist. Treatment was initiated according to the 
results of the clinical examination and initial infective screen, 1324 MCGREADY AND OTHERS
and they could be changed if new results became available. 
Aural temperature, blood pressure, pulse, and respiratory rate 
were recorded every 6 hours. Patients were reviewed daily, 
and the symptom checklist was repeated. Body temperature 
was measured by an aural thermometer with disposable 
covers (Genius). Fever clearance time (FCT) was defined as 
the time from onset of treatment to the first time that aural 
temperature dropped below 37.5°C and remained < 37.5°C 
for 24 hours. Pyelonephritis was diagnosed if a significant 
growth on urine culture was accompanied by consistent 
clinical signs (systemic features such as fever, chills, nausea, 
vomiting, or flank pain or costovertebral angle tenderness) or 
if there were consistent clinical signs and a valid reason for 
the urine culture to be negative (e.g., antibiotics in the past 72 
hours). Asymptomatic UTI was defined as a significant growth 
on urine culture and non-clinical symptoms or signs of UTI. 
Anemia was defined by a hematocrit < 30%, and severe anemia 
was defined by a hematocrit < 20%. Teenager was defined as 
aged < 20 years. 
   Mother  and  infant  follow-up.     After discharge, patients were 
followed up weekly at their regular antenatal clinic, where 
they were asked about fever and other symptoms and signs 
in the preceding week. Standardized symptom screening 
and physical and obstetric examinations were continued for 
6 weeks. Women who had been diagnosed with pyelonephritis 
were reviewed weekly for 6 weeks with repeat urine dipsticks, 
repeat urine sediment, and cultures at days 14 and 42. Any 
positive sample by dipstick (WBC and nitrite positive) was 
followed by microscopy of urine sediment and culture. Any 
patient with symptoms at any time by day 42 had repeat 
urine stick, sediment, and culture. Deliveries were supervised 
whenever possible, although many women chose to deliver at 
home. Gestational age was assessed by ultrasound (≤ 24 weeks 
gestation) or by the Dubowitz score in women with either a 
late or no ultrasound.  32   Birth weight was assessed in all infants 
that were seen after birth, but analysis for birth outcomes was 
restricted to those weighed in the first 72 hours of life. Where 
possible, all infants were examined again at 1 month of age. 
Low birth weight was defined by a birth weight < 2,500 g, 
pre-term delivery was defined by a gestational age < 37 weeks, 
and an abortion was defined by a delivery < 28 weeks. 
   Treatment.     Paracetamol was given at a dose of 1 g every 
8 hours for the first 48 hours if fever continued. Tepid sponging 
and fanning was used when necessary to control the fever. 
Patients were asked to drink at least 1 L of water every 8 
hours or were treated with IV fluids if unable to tolerate oral 
fluids. Pyelonephritis was treated with ceftriaxone 1 g IV every 
24 hours for 10–14 days unless susceptibility testing indicated 
a change to a different antibiotic. 
   Analysis.     Data were described using the statistical program 
SPSS for Windows (Version 14; SPSS Benelux Inc., Gorinchem, 
The Netherlands). Continuous normally distributed data were 
described by the mean (standard deviation and range), and 
non-normally distributed data were described by the median 
(range). Percentages were given for categorical data. The 
sensitivity, specificity, and positive and negative predictive 
values of urine dipstick and urine sediment microscopy were 
compared with urine culture. Contaminated culture and urine 
sediment microscopy results were excluded for the purpose of 
this analysis. 
   Ethical  clearance.     Informed consent was obtained from 
all participants, and the study was approved by the Oxford 
Tropical Research Ethics Committee, United Kingdom 
(#013-03). 
    RESULTS 
  During the study period between January 7, 2004 and May 
17, 2006, 203 febrile women consented to participate, of whom 
41 were diagnosed with pyelonephritis and 1 was diagnosed 
with an asymptomatic UTI in association with acute   P. falci-
parum  infection. The mean maternal age of women with pyelo-
nephritis was 26 ± 7 (16–40) years, of whom 39% (16/41) were 
primigravida and 19.5% (8/41) were teenagers. A total of 4,819 
deliveries at Shoklo Malaria Research Unit (SMRU) were 
recorded during the same period. There were 12 further cases 
of pyelonephritis in pregnant women who did not participate 
in the study, giving an overall incidence of 1.1% (53/4,819) or 
11/1,000 deliveries. 
  Urine dipstick, urine sediment microscopy, and urine culture 
results.     Results were not available for urine dipstick in 3.4% 
(7/203) of women, urine sediment microscopy in 1.5% (3/203) 
of women, and urine culture in 0.5% (1/203) of women. The 
overall proportion of women with positive results on urine 
dipstick was high (  Table 1  ). There were 82 of 196 (41.8%) 
women with detectable hematuria, and 38.8% (76/196) of 
women had ketones. There were 13.3% (26/196) positive for 
leukocytes and nitrite on dipstick testing, and 5.1% (10/196) 
were negative for leukocytes but positive for nitrite. Of the 
women whose urine samples tested positive for leukocytes and 
nitrites, 53.8% (14/26) had positive urine culture (  Table 1  ). 
          There were 24 of 200 (12.0%) contaminated urine sediment 
samples using the criteria outlined above. After excluding these 
samples, positive urine sediment microscopy was observed 
in 28.4% (50/176) of samples. Of these, 54.0% (27/50) were 
urine culture positive, and in the women for whom dipstick 
 Table 1 
    Urine dipsticks in febrile pregnant women on the Thai–Burmese 
border 2004–2006   
Investigation Result   N   (196) Percent
Leukocyte 
(alone)
Negative 98 50.0
1+ 37 18.9
2+ 36 18.4
3+ 25 12.8
Nitrites (alone) Positive 36 18.4
Negative 160 81.6
Leukocyte and 
nitrites
Leukocyte and nitrite negative 88 44.9
Leukocyte and nitrite positive 26 13.3
Leukocyte positive and nitrite 
negative 72 36.7
Leukocyte negative and nitrite 
positive 10 5.1
Protein Negative 110 56.1
1+ 76 38.8
2+ 8 4.1
3+ 2 1.0
Ketones Negative 120 61.2
1+ 28 14.3
2+ 26 13.3
3+ 22 11.2
Glucose Negative 189 96.4
> 1+ 7 3.6
Blood Blood 82 41.8
RBC 56 68.3 (56/82)
Hemoglobin 26 31.7 (26/82)
No blood 114 58.21325 DIFFICULTIES OF PYELONEPHRITIS IN PREGNANCY
was available, leukocytes and nitrites were positive in 30.6% 
(15/49) of samples.   Trichomonas   was detected in urine in 1% 
(2/200) of women. 
  In specimens where the urine sediment and urine culture 
were not reported as contaminated, urine culture results were 
reported as no or non-significant growth in 81.2% (138/170) 
and positive growth in 18.8% (32/170) of the samples. Of the 
32 positive urine cultures, only 1 was considered to be unre-
lated to the presenting fever in a woman diagnosed and treated 
with artesunate for   P. falciparum   infection. Her fever resolved 
before the urine culture result (  Escherichia coli   > 10  5   cfu/mL) 
was available, but she was treated with nitrofurantoin for 
7 days and was culture negative on day 42 of follow-up. 
  In specimens where the urine sediment and urine culture 
were not reported as contaminated, urine sediment micros-
copy and urine dipstick results were compared with urine 
culture results using sensitivity, specificity, and positive and 
negative predictive values (  Table 2  ). The use of blood and/
or protein on urine dipsticks was poorly predictive for a posi-
tive urine culture. Whereas the combination of leukocytes and 
nitrites gave the highest positive predictive value for a positive 
urine culture, the sensitivity was only 44%, lower than nitrites 
alone (  Table 2  ). The use of microscopy of urine sediment, 
which combines WBC, bacteria, and epithelial cells, provided 
the highest sensitivity, specificity, and negative predictive value 
overall, but the positive predictive value was low. In this series, 
lowering the urine sediment cut-off to WBC ≥ 7/HPF resulted 
in a higher sensitivity than WBC ≥ 10/HPF (  Table 2  ), but it did 
not improve the positive predictive value. 
        Pyelonephritis.     Of the 203 women in the original cohort, 41 
women were diagnosed with pyelonephritis, of which 78.0% 
(32) had a positive urine culture. The diagnosis of pyelonephritis 
included 21.9% (9/41) of women with no significant growth 
on urine culture. Seven of these women had documented 
antibiotic intake in the 72 hours before the sample for culture. 
Urinary pathogens cultured from urine were   E. coli   (87.5%; 
28/32),  Citrobacter  sp. (1/32),  Enterococcus  sp. (1/32),  Klebsiella  
sp. (1/32), and   K. oxytoca  . Five of the specimens had a count 
of 10  4   cfu/mL (three   E. coli   and one each of   Enterococcus   sp. 
and   K. oxytoca  ), whereas the remainder contained at least 
10  5   cfu/mL. 
  All women with a positive urine culture had a hemocul-
ture performed. One woman had a blood culture positive for 
a coagulase-negative   Staphylococcus  , which was presumed to 
be a contaminant, and of the remaining women, 25% (8/32) 
had concurrent positive hemoculture with the same organism 
(all   E. coli ). 
   Antimicrobial  susceptibility.     E. coli   isolates were suscep-
tible to ceftriaxone (100%), nitrofurantoin (96%), cipro-
floxacin (97%), nalidixic acid (93%), and gentamicin (93%) 
(  Figure 1  ). The rate of   E. coli   susceptibility to ampicillin 
(14%) and cotrimoxazole (21%) was very low. Susceptibility 
to amoxicillin-clavulanic acid (48%) was also low. Organisms 
isolated from hemoculture showed the same antimicrobial 
susceptibility patterns as the matched urinary isolate from 
the same patient. Susceptibility to ceftazidime and cefoxitin 
was reported for 24 of 29   E. coli   isolates. Only one isolate 
was identified as producing an ESBL (4.2%; 95% confidence 
interval [CI] = 0.7–19.5). The single   Enterococcus   sp. was 
sensitive to ampicillin. The   Citrobacter   sp. was resistant to 
ampicillin and cotrimoxazole but sensitive to nitrofurantoin, 
ciprofloxacin, cephalosporins, and amoxicillin-clavulanic acid. 
  The antimicrobial susceptibilities of urinary pathogens on 
the Thai–Burmese border in refugee and migrant women were 
compared with data for   E. coli   isolates from outpatient UTI 
samples obtained from the National Resistance Surveillance 
Center (NRSC) of Thailand for 2006 (  Figure 1  ).   E. coli   iso-
lates from refugee and migrant women were more likely to 
be resistant to ampicillin/amoxicillin and cotrimoxazole than 
the   E. coli   in the 2006 NRSC Thailand community acquired 
series. Although rarely prescribed, amoxicillin-clavulanic acid 
had a lower rate of susceptibility for   E. coli   from refugee and 
migrant women. 
   Risk  factors  for  pyelonephritis.     The proportion of primi-
gravida with pyelonephritis was significantly higher than 
multigravida (1.9% [21/1,082] versus 0.9% [32/3,737],   P   = 
0.004). There was no significant difference in mean maternal 
age in women with (26.1 ± 6.7 years) and without pyelonephritis 
(26.7 ± 6.7 years,   P   = 0.531). The mean gestation at the time 
 Table 2 
    Comparison of urine sediment microscopy and urine sticks as predictors of positive urine culture results   
  Epithelial  cells  < 5/HPF using lower limit of range.   
Urine sediment microscopy Urine stick leukocyte and nitrite Urine stick blood and protein
Epithelial cells < 5; 
WBC ≥ 10
Epithelial cells < 5; 
WBC ≥ 7
Leukocyte and 
nitrite positive
Leukocyte 
positive
Nitrite 
positive Blood Protein Blood and protein Blood or protein
Sensitivity (%) 84 97 44 88 47 72 56 44 72
Specificity (%) 84 82 92 59 86 66 60 82 41
Positive predictive value (%) 55 55 58 34 46 33 25 37 22
Negative predictive value (%) 96 99 80 95 87 91 85 86 87
  Figure   1.        Antimicrobial sensitivity (%) in   E. coli   isolates in febrile 
pregnant migrant and refugee women (January 4 to May 6) and in out-
patients from the National Resistance Surveillance Center, Thailand 
(2006). *Zero value means no data were available.       1326 MCGREADY AND OTHERS
of infection was 22.8 ± 9.5 (5.6–41.2) weeks, with the highest 
frequency of infection in the second (51.2%; 21/41) followed 
by the third (31.7%; 13/41) and first trimesters (17.1%; 7/41). 
The mean gestational age of women at the time of diagnosis 
was significantly higher in women with bacteremia than those 
without bacteremia (30.7 ± 7.1 versus 20.4 ± 8.7 weeks,   P   = 
0.004). Women with pyelonephritis associated with bacteremia 
(  N   = 8) had higher admission temperature, longer fever 
clearance times, lower blood pressure, and younger maternal 
age than those without bacteremia, although these were not 
significant (data not shown). No significant differences in 
hematological parameters at baseline were observed between 
women with and without bacteremia (data not shown). 
Ultrasound findings were not included here, because it was 
not consistently available for all women. 
      Clinical symptoms and antimicrobial therapy.    Women 
with pyelonephritis were very symptomatic (  Figure 2  ). Cos-
tovertebral angle pain was the most common symptom 
reported. More than one-quarter of women reported vomit-
ing. The median days of fever reported before diagnosis were 
3 (1–10), with nearly one-half (46.3%; 19/41) presenting to the 
clinic with a history of fever of 2 days or less. Nearly one-half 
(48.8%; 20/41) of women reported antibiotic use at some stage 
in their pregnancy before admission, and 41.5% (17/41) of 
women reported prior treatment in their lives for UTI. There 
were 27 of 41 (65.9%) women who had renal tract ultrasound 
during their hospitalization. In one-half of these cases (51.9%; 
14/27), the kidney was reported to be abnormal: nephrolithia-
sis in 3 women and hydronephrosis in 11 women. 
    Nearly all women (90.2%; 37/41) with pyelonephritis were 
treated with ceftriaxone 1 g daily in a single dose for 7–14 days. 
Three of the remaining women were treated with IV ampicil-
lin plus gentamicin or oral amoxicillin-clavulanic acid, and one 
woman received azithromycin and nitrofurantoin. The median 
(range) time in days to fever clearance from admission was 2 
(1–8). There were three women who had a culture-confirmed 
repeat episode of UTI after ceftriaxone treatment, two on day 
42 with repeat   E. coli   and one on day 107 that was also   E. coli  
after a first infection with   K. oxytoca.   The original and subse-
quent antibiograms of these three subsequent infections did 
not indicate more resistant strains. The day 42 cure rate of 
  E. coli   pyelonephritis treated with ceftriaxone in pregnancy 
was 91.9% (95% CI = 78.7–97.2). 
   Pregnancy  outcome.     Of the 41 women with pyelonephritis, 
7.3% (3) left the study area before pregnancy outcome was 
known. Among the remaining 38 women, 94.7% (36) delivered 
(all live born) and 5.3% (2) aborted. The mean (± standard 
deviation) gestation of delivered infants was 38.9 ± 2.5 (29.2–
42.5) weeks, and 8.3% (3/36) of infants were born pre-term 
(29 + 2, 32 + 0, and 35 + 4 weeks). Two of these premature 
births occurred while the woman was still on treatment: day 
4 and day 7. Among women who delivered, 97.2% (35/36) of 
infants were weighed within 72 hours of birth. There were 
14.3% (5/35) of infants with low birth weight, and the mean 
(± standard deviation) birth weight was 2,956 ± 573 g. There 
was one abnormal infant with Down’s syndrome (gestation of 
UTI was 25.4 weeks). All infants, including the infant born at 
29 weeks gestation, were alive at 1 month. 
    DISCUSSION 
  As expected,   E. coli   was the most commonly isolated uri-
nary pathogen, accounting for 87.5% of acute pyelonephritis 
and confirming similar rates from previous reports in preg-
nancy.  17,  20,  33–  36   Ampicillin, previously the drug of choice for 
  E. coli   antepartum pyelonephritis because of its efficacy, 
cost, and safety for the mother and fetus, has been lost to 
global resistance.  37   With a rate of ampicillin susceptibility 
for   E. coli   of only 14% on the Thai–Burmese border, it rep-
resents an unacceptable choice for febrile UTI in pregnancy. 
Low rates of susceptibility to ampicillin, cotrimoxazole, and 
amoxicillin-clavulanic acid have been reported in most of 
Europe  17,  38–  40   and the United States.  37,  41   The low rates of sus-
ceptibility to ampicillin, cotrimoxazole, and amoxicillin-clavu-
lanic acid and the high rates of susceptibility to ceftriaxone, 
nitrofurantoin, ciprofloxacin, nalidixic acid, and gentamicin 
in our study are likely to have resulted from antimicrobial 
prescribing patterns in the camp, which have not changed for 
20 years. The refugee camps on the Thai–Burma border have 
used oral ampicillin or amoxycillin for outpatient UTI and 
IV ampicillin and gentamicin for hospitalized patients since 
their inception in 1986. The latest guidelines contain changes 
in recommended regimens for urinary tract pathogens 
based primarily on the evidence presented here. 
  More than 10 years ago, Biedenbach and others  42   reported 
high antimicrobial resistance in Thailand among commonly 
encountered pathogens and a rate of ESBL production of 
15.7% for   E. coli   and 45.6% for   K. pneumoniae . 42   The  EBSL 
rate among urinary   E. coli   in this series (2004–2006) was low at 
4%. Plausible explanations for the low rate of ESBL in these 
isolates are that (1) literature reports are often biased to noso-
comial infections and this is highly likely to select for a higher 
rate of ESBL-producing organisms, and (2) the response rate 
to the treatment (ceftriaxone 1 g IV       once daily) used sug-
gests that ESBL was not common.  43   ESBL rates are likely 
to change in the coming years with the change in prescrib-
ing practices and the high rates of ESBL-producing strains in 
  E. coli   reported from intra-abdominal infections in the Asia–
Pacific region and Thailand (42.2% and 50.8%, respectively) 
in 2007.  44  
  Without an overview of the organisms and susceptibil-
ity patterns, it is very difficult to generate useful guidelines 
and reduce death from sepsis in resource-limited settings.  10  
Medical care in refugee settings is often the domain of NGOs. 
Practice guidelines tend to be generated from headquarters 
  Figure   2.        Symptoms reported on admission in pregnant women 
with pyelonephritis. Cva = costovertebral angle.       1327 DIFFICULTIES OF PYELONEPHRITIS IN PREGNANCY
and may not be country (even continent)-specific. Most NGOs 
use restricted lists of essential drugs. Collating and analyzing 
local microbiological results, if there are any, is rarely part of 
an NGO’s mandate. If individual patient data cannot be col-
lected, routinely intermittent surveillance could prove use-
ful. This could improve survival in sepsis in resource-limited 
settings.  45  
 The incidence of acute antepartum pyelonephritis was 1.1%, 
which is similar to that reported with antepartum universal 
screening (1–2%).  3,  17   This is reassuring, because a high rate 
of chronic renal disease has been reported from Thailand.  46  
Pyelonephritis accounted for 20% of fever presentations in 
febrile pregnant women on the Thai–Burmese border. This is 
in contrast to a fever study in adults conducted 300 km south 
of the sites in this manuscript, where only 2.1% (13/613) of 
diagnoses among febrile adults (aged 20–87 years, 53.1% 
male) were pyelonephritis.  47   Concomitant   E. coli   bacteremia 
and urinary sepsis in women in this prospective cohort were 
higher (25%) than similar prospective studies where rates of 
14.4% (13/90)  20   or 8.4% (15/179)  48   were reported. This reaf-
firms the need for prompt and effective treatment of this con-
dition in this setting. 
  Pyelonephritis is essentially a clinical diagnosis. The sensi-
tivity and specificity of leukocyte esterase and nitrites in this 
cohort are in agreement with a meta-analysis that found sen-
sitivity and specificity of nitrites were around 50% and 95%, 
whereas leukocyte esterase was highly variable, with a sensi-
tivity of 50–60% and a lower specificity than nitrites.  49   It has 
been suggested that nitrites alone indicate the need for fur-
ther urine testing and could be used to initiate treatment,  50  
which would overtreat a large percentage of patients in this 
setting. Urine sediment microscopy proved more sensitive 
than urine dipsticks for diagnosis of pyelonephritis. A WBC 
count of ≥ 7/HPF in the presence of bacteria and with epi-
thelial cell count < 5/HPF predicted a positive urine culture 
with the highest sensitivity, but this was not as specific as 
WBC count of ≥ 10/HPF or the presence of leukocytes and 
nitrites on urine dipstick. In areas where microscopy is prac-
ticed routinely to diagnose malaria and microbiological facili-
ties are not available, the urine sediment is likely to provide a 
cheap alternative for urine examination. Cut-offs are best con-
firmed with microbiological support, but this could be done 
as a survey. Known limitations of the dipstick nitrite test in 
diagnosing bacteriuria include infection with non–nitrite-pro-
ducing pathogens and insufficient time since the last void for 
nitrites to appear at detectable levels (ideally, at least 4 hours); 
in this setting, another limitation is possibly a lack of dietary 
nitrate.  51  
  The women studied here were a select group presenting 
with fever. The results are likely to be different than if all preg-
nant women had been screened to detect asymptomatic bac-
teriuria.  52   This study suggests that antibiotics that can be used 
to treat pyelonephritis in this area include ceftriaxone, cipro-
floxacin, and gentamicin. A number of publications including 
a meta-analysis on first trimester exposures suggest that cip-
rofloxacin use is not associated with increased risk of adverse 
events in pregnancy. Data from pregnant patients with inflam-
matory bowel disease and tuberculosis also suggest that cipro-
floxacin is safe.  53,  54   Ceftriaxone requires IV or intramuscularly 
treatment, whereas ciprofloxacin can be given orally; addi-
tionally, patients can ambulate and be treated as outpatients. 
A 7-day regimen of nitrofurantoin has recently been described 
as an adequate choice for asymptomatic bacteriuria in 
Southeast Asia,  55   and this recommendation is consistent with 
the susceptibilities reported here. Treatment changes based 
on the findings of this cohort were implemented in 2007. 
Microbiological capacity in the area has improved, and all 
suspected UTIs in pregnancy are cultured. In glucose-6 phos-
phate dehydrogenase deficiency negative       women and unless 
otherwise suggested by an antibiogram, treatment is with 7 
days of nitrofurantoin for uncomplicated UTIs and 10–14 days 
oral ciprofloxacin or IV ceftriaxone (if oral ciprofloxacin is 
not tolerated) for complicated UTI (fever, upper urinary tract 
signs, pyelonephritis, or abnormal ultrasound findings). In 
resource-limited settings, cost is an important issue: a 14-day 
course of oral ciprofloxacin (500 mg twice daily      ) purchased in 
Thailand costs approximately 80 baht (US $3.50) versus 980 
baht (US $30.25) for ceftriaxone (1 g once daily; exchange rate 
is 32.4 baht to US $1). Screening for asymptomatic bacteriuria 
remains the ideal for pregnant women and is currently under 
consideration. 
  There was difficulty in this population to obtain a clean 
catch urine specimen. Up to 12% of specimens had a high 
number of epithelial cells, suggesting suboptimal specimen 
collection. Although a clean voided urine specimen with prior 
cleansing of the urethra and perineum is standard practice,  56  
there is no consistent recommendation for how this should be 
done.  17   Attention to this detail must be included in screening 
asymptomatic women. 
  The birth outcomes in women with treated pyelonephritis, 
particularly low birth weight and prematurity, were similar to 
those recently reported in women prospectively followed in 
an uncomplicated malaria treatment trial from the same area 
in the same years.  57   Further comparison on a larger number of 
women with pyelonephritis is planned. 
  In conclusion, acute pyelonephritis in pregnant refugee and 
migrant women occurred at the expected rate, and the pre-
dominant pathogen in this area was   E. coli .  Ampicillin,  cot-
rimoxazole, and amoxicillin-clavulanic acid are unsuitable 
antimicrobials for the treatment of   E. coli   pyelonephritis on 
the Thai–Burmese border. Ceftriaxone and ciprofloxacin are 
more likely to result in cure of the patient. Ciprofloxacin is 
not licensed for use in pregnancy; however, recent literature 
and cost make it a viable alternative in resource-poor settings. 
Urine sediment fared somewhat better than urine dipsticks for 
diagnosis of culture-positive urine, but the positive predictive 
value of both were poor. Innovations in microbiology diag-
nostics that permit access at a low cost are a high priority for 
resource-poor settings. 
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